Download PDF
Int J Angiol
DOI: 10.1055/s-0044-1785488
Original Article

Endothelial-Derived Microparticles Associate with Hospital Major Adverse Cardiovascular Events but not with Long-Term Adverse Events in Acute Myocardial Infarction

Anggoro B. Hartopo 
1   Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada–Dr. Sardjito Hospital, Yogyakarta, Indonesia
,
Dyah S. Mayasari
1   Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada–Dr. Sardjito Hospital, Yogyakarta, Indonesia
2   Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada – UGM Academic Hospital, Yogyakarta, Indonesia
,
Ira Puspitawati
3   Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada–Dr. Sardjito Hospital, Yogyakarta, Indonesia
,
Astrid K. Putri
1   Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada–Dr. Sardjito Hospital, Yogyakarta, Indonesia
,
Budi Y. Setianto
1   Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada–Dr. Sardjito Hospital, Yogyakarta, Indonesia
› Author Affiliations FundingThe research received funding from: (1) Penelitian Fundamental Number 1047/UN1-P.III/LT/DIT-LIT/2016 from Universitas Gadjah Mada and (2) Academic Excellence Improvement Program Number 7725/UN1.P.II/Dit-Lit/PT.01.03/2023 from Universitas Gadjah Mada to A.B.H. (as Principal Investigator).
› Further Information
    Permissions and Reprints

Abstract

Endothelial-derived microparticles (EDMP) are markers of vascular function and convey roles in coagulation, inflammation, vasoactivity, angiogenesis, and cellular apoptosis, which implicate acute myocardial infarction (AMI). This study aimed to investigate whether, among AMI, on-admission EDMP counts affect hospital major adverse cardiovascular events (MACE) and whether the change of EDMP in 30-day posthospital discharge affects long-term follow-up MACE. The research design was a prospective cohort study. The subjects were 119 patients diagnosed and hospitalized with AMI, who were enrolled consecutively. The EDMP was measured on hospital admission and repeated 30-day posthospital discharge. The outcomes were in the hospital MACE comprised of cardiac mortality, heart failure, cardiogenic shock, reinfarction, and resuscitated ventricular arrhythmia. Furthermore, long-term follow-up were performed on 30-day, 90-day, and 1-year posthospital AMI discharge. The on-admission EDMP counts were significantly higher in subjects with hospital MACE compared with those without (median [interquartile range]: 27,421.0 [6,956.5–53,184.0] vs. 11,617.5 [4,599.0–23,336.7] counts/µL, p = 0.028). The EDMP counts cutoff value of >26,810.0 counts/µL (52.4% sensitivity, 81.6% specificity) had significantly increased hospital MACE occurrence (adjusted odd ratio: 4.45, 95% confidence interval: 1.47–13.53, p = 0.008). The EDMP counts were significantly increased after 30-day posthospital discharge. Both on-admission and 30-day EDMP counts and the changes in EDMP counts did not impact MACE on the long-term follow-up. In conclusion, higher on-admission EDMP counts were independently associated with hospital MACE among AMI. However, on-admission and 30-day postdischarge EDMP and their changes did not impact long-term follow-up MACE.

Keywords

cardiovascular disease - cell-derived microparticle - myocardial infarction - prognosis


Publication History

Article published online:
02 April 2024

© 2024. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Nomura S. Microparticle and atherothrombotic diseases. J Atheroscler Thromb 2016; 23 (01) 1-9
    CrossrefPubMedGoogle Scholar
  • 2 Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011; 31 (01) 27-33
    CrossrefPubMedGoogle Scholar
  • 3 Bernal-Mizrachi L, Jy W, Jimenez JJ. et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003; 145 (06) 962-970
    CrossrefPubMedGoogle Scholar
  • 4 Zielińska M, Koniarek W, Goch JH. et al. Circulating endothelial microparticles in patients with acute myocardial infarction. Kardiol Pol 2005; 62 (06) 531-542 , discussion 543–544
    PubMedGoogle Scholar
  • 5 Stępień E, Stankiewicz E, Zalewski J, Godlewski J, Zmudka K, Wybrańska I. Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation. Arch Med Res 2012; 43 (01) 31-35
    CrossrefPubMedGoogle Scholar
  • 6 Zhang Y, Cheng J, Chen F. et al. Circulating endothelial microparticles and miR-92a in acute myocardial infarction. Biosci Rep 2017; 37 (02) BSR20170047
    CrossrefPubMedGoogle Scholar
  • 7 Mallat Z, Benamer H, Hugel B. et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101 (08) 841-843
    CrossrefPubMedGoogle Scholar
  • 8 Suades R, Padró T, Crespo J. et al. Circulating microparticle signature in coronary and peripheral blood of ST elevation myocardial infarction patients in relation to pain-to-PCI elapsed time. Int J Cardiol 2016; 202: 378-387
    CrossrefPubMedGoogle Scholar
  • 9 Min PK, Kim JY, Chung KH. et al. Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction. Atherosclerosis 2013; 227 (02) 323-328
    CrossrefPubMedGoogle Scholar
  • 10 Zacharia E, Antonopoulos AS, Oikonomou E. et al. Plasma signature of apoptotic microvesicles is associated with endothelial dysfunction and plaque rupture in acute coronary syndromes. J Mol Cell Cardiol 2020; 138: 110-114
    CrossrefPubMedGoogle Scholar
  • 11 Jung C, Sörensson P, Saleh N, Arheden H, Rydén L, Pernow J. Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. Atherosclerosis 2012; 221 (01) 226-231
    CrossrefPubMedGoogle Scholar
  • 12 Sionis A, Suades R, Sans-Roselló J. et al. Circulating microparticles are associated with clinical severity of persistent ST-segment elevation myocardial infarction complicated with cardiogenic shock. Int J Cardiol 2018; 258: 249-256
    CrossrefPubMedGoogle Scholar
  • 13 Hartopo AB, Mayasari DS, Puspitawati I, Mumpuni H. Circulating platelet-derived microparticles associated with post-discharge major adverse cardiac events in ST-elevation acute myocardial infarction. Cardiol Res Pract 2020; 2020: 6721584
    CrossrefPubMedGoogle Scholar
  • 14 Koganti S, Eleftheriou D, Gurung R, Hong Y, Brogan P, Rakhit RD. Persistent circulating platelet and endothelial derived microparticle signature may explain on-going pro-thrombogenicity after acute coronary syndrome. Thromb Res 2021; 206: 60-65
    CrossrefPubMedGoogle Scholar
  • 15 Lu Y, Li L, Yan H, Su Q, Huang J, Fu C. Endothelial microparticles exert differential effects on functions of Th1 in patients with acute coronary syndrome. Int J Cardiol 2013; 168 (06) 5396-5404
    CrossrefPubMedGoogle Scholar
  • 16 Christersson C, Thulin Å, Siegbahn A. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events. Thromb Haemost 2017; 117 (08) 1571-1581
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Landers-Ramos RQ, Addison OA, Beamer B. et al. Circulating microparticle concentrations across acute and chronic cardiovascular disease conditions. Physiol Rep 2020; 8 (15) e14534
    PubMedGoogle Scholar
  • 18 Suades R, Greco MF, Padró T, Badimon L. Extracellular vesicles as drivers of immunoinflammation in atherothrombosis. Cells 2022; 11 (11) 1845
    CrossrefPubMedGoogle Scholar
  • 19 Mobarrez F, Egberg N, Antovic J, Bröijersen A, Jörneskog G, Wallén H. Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study. Thromb Res 2012; 129 (01) 95-97
    CrossrefPubMedGoogle Scholar
  • 20 Marei I, Chidiac O, Thomas B. et al. Angiogenic content of microparticles in patients with diabetes and coronary artery disease predicts networks of endothelial dysfunction. Cardiovasc Diabetol 2022; 21 (01) 17
    CrossrefPubMedGoogle Scholar